0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
RSS Email Alerts
Please Wait... Processing your request... Please Wait.

JAMA Oncology | 
Invited Commentary | 
Elena M. Stoffel, MD, MPH; Eric R. Fearon, MD, PhD
JAMA Oncol. 2016;2(4):491-492. doi:10.1001/jamaoncol.2015.5622.

JAMA Oncology | 
Original Investigation | 
Barbara M. Norquist, MD; Maria I. Harrell, PhD; Mark F. Brady, PhD; et al.
JAMA Oncol. 2016;2(4):482-490. doi:10.1001/jamaoncol.2015.5495.
Includes: Supplemental Content

JAMA Neurology | 
Original Investigation | 
Thaís Armangué, MD, PhD; Lidia Sabater, PhD; Estefanía Torres-Vega, BSc; et al.
JAMA Neurol. 2016;73(4):417-424. doi:10.1001/jamaneurol.2015.4607.
Includes: Supplemental Content

JAMA | 
Viewpoint |  FREE ONLINE FIRST
Douglas A. Levine, MD; Beth Y. Karlan, MD; Jerome F. Strauss III, MD, PhD
JAMA. Published online March 02, 2016. doi:10.1001/jama.2016.2640

JAMA Oncology | 
Brief Report | 
Elizabeth M. Swisher, MD; Maria I. Harrell, PhD; Barbara M. Norquist, MD; et al.
JAMA Oncol. 2016;2(3):370-372. doi:10.1001/jamaoncol.2015.6053.
Includes: Supplemental Content

JAMA | 
Clinical Trials Update | 
Anita Slomski, MA
JAMA. 2016;315(8):742. doi:10.1001/jama.2016.0481.

JAMA | 
Original Investigation | 
Lorelei A. Mucci, ScD, MPH; Jacob B. Hjelmborg, PhD; Jennifer R. Harris, PhD; et al.
JAMA. 2016;315(1):68-76. doi:10.1001/jama.2015.17703.
Includes: CME, Supplemental Content

JAMA Oncology | 
Viewpoint | 
Elisa F. Long, PhD; Patricia A. Ganz, MD
JAMA Oncol. 2015;1(9):1217-1218. doi:10.1001/jamaoncol.2015.2340.
Includes: Supplemental Content

JAMA Oncology | 
Original Investigation |  Open Access
Joanne Armstrong, MD, MPH; Michele Toscano, MS; Nancy Kotchko, MA; et al.
JAMA Oncol. 2015;1(9):1251-1260. doi:10.1001/jamaoncol.2015.3048.

JAMA Neurology | 
Observation | 
Andrew D. Smith III, MD; Lawrence Samkoff, MD
JAMA Neurol. 2015;72(11):1375-1377. doi:10.1001/jamaneurol.2015.1531.

Sign in

Purchase Options

• Subscribe to the journal
• Rent this article ?

A free personal account provides

• Free current issues on The JAMA Network Reader
• Free quizzes on The JAMA Network Challenge
• Commenting and personalized alerts
Related JAMA Network Collections
From The JAMA Network
JAMA Neurology
Original Investigation  | 
Clinical and Immunological Features of Opsoclonus-Myoclonus Syndrome in the Era of Neuronal Cell Surface Antibodies
Thaís Armangué, MD, PhD; Lidia Sabater, PhD; Estefanía Torres-Vega, BSc; et al.
JAMA Oncology
Invited Commentary  | 
Germline Sequence Variants and Ovarian Cancer Known-Knowns and Known-Unknowns
Elena M. Stoffel, MD, MPH; Eric R. Fearon, MD, PhD
JAMA Oncology
Original Investigation  | 
Inherited Mutations in Women With Ovarian Carcinoma
Barbara M. Norquist, MD; Maria I. Harrell, PhD; Mark F. Brady, PhD; et al.
JAMA
Viewpoint  | 
Evolving Approaches in Research and Care for Ovarian Cancers A Report From the National Academies of Sciences, Engineering, and Medicine
Douglas A. Levine, MD; Beth Y. Karlan, MD; Jerome F. Strauss III, MD, PhD